Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
17 Gennaio 2024 - 5:44PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 under the
Securities Exchange Act of 1934
January
17, 2024
Commission
File Number 001-14978
SMITH & NEPHEW plc
(Registrant’s
name)
Building 5, Croxley Park, Hatters Lane
Watford, England, WD18 8YE
(Address
of principal executive office)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form
20-F Form 40-F
__
SMITH & NEPHEW PLC
17 January 2024
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE
REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY
PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND
PERSONS CLOSELY ASSOCIATED WITH THEM.
On 17 January 2024, Smith & Nephew plc (the "Company") received
notification of the following transactions as detailed
below.
|
Reason for the notification
|
|
Initial
notification /Amendment
|
Initial
notification
|
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
Name
|
Smith
& Nephew plc
|
|
LEI
|
213800ZTMDN8S67S1H61
|
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|
Description
of the financial instrument, type of instrument
|
Smith
& Nephew plc SPON ADR American Depositary Shares
(ADS)
|
|
Identification
code
|
ISIN:
US83175M2052
|
|
Nature
of the transaction
|
Purchase
of American Depository Shares as participants of the Company's
Employee Stock Purchase Plan
|
|
Date of
Transaction
|
2024 -
01 - 08 and 2024 - 01 - 09
|
|
Place
of Transaction
|
New
York Stock Exchange
|
|
Name
(Position)
|
Director / PDMR
|
Price ($)
|
Volume
|
Aggregated information
|
|
Bradley
Cannon
(President
Sports Medicine & ENT)
|
PDMR
|
23.19
|
408.49634
|
N/A
Single Transaction
|
|
Mizanu
Kebede
(Chief
Quality & Regulatory Affairs Officer)
|
PDMR
|
23.19
|
96.29754
|
N/A
Single Transaction
|
|
Deepak Nath
(Chief Executive Officer)
|
Director
|
23.19
|
408.49634
|
N/A
Single Transaction
|
|
Paul Connolly
(President, Global Operations)
|
PDMR
|
23.19
|
408.49634
|
N/A
Single Transaction
|
|
Scott Schaffner
(President, Sports Medicine)
|
PDMR
|
23.19
|
232.8564
|
N/A
Single Transaction
|
*All figures in these columns are stated to 5 decimal places where
applicable.
Sarah Carne
Deputy Company Secretary
Smith & Nephew plc
Tel: +44 (0)1923 477410
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
Smith & Nephew plc
|
|
|
|
(Registrant)
|
|
|
|
|
|
|
|
|
|
Date:
January 17, 2024
|
By:
|
/s/
Helen Barraclough
|
|
|
|
Helen
Barraclough
|
|
|
|
Company
Secretary
|
Grafico Azioni Smith and Nephew (NYSE:SNN)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni Smith and Nephew (NYSE:SNN)
Storico
Da Dic 2023 a Dic 2024
